PTPN14 | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

23 results for “PTPN14”

Trials

Correlation Between PTP1B Expression and Organ Failure During Sepsis

54 participants · First posted Nov 20, 2014

Prediction of Benefit From Adjuvant Chemotherapy for pT1N1 Gastric Cancer

1,000 participants · First posted Apr 2, 2018

Study of PTPN22 C1858T Polymorphism in Children and Adolescents of Greek Origin With T1DM

200 participants · First posted Jan 13, 2011

Drugs

View all 10 →

PPS14 PCMV

PTPN13/fas inhibitors (pulmonary fibrosis)

PTPN1/N2 checkpoint inhibitor (cancer)

News

Lantern Pharma Secures USPTO Notice of Allowance for Biomarker-Guided Patent on LP-184 in Multiple Solid Tumors

Kura Oncology and Kyowa Kirin's Ziftomenib Achieves Primary Endpoints in Phase II AML Trial

Mondego Bio Advances AI-Designed PTPN2 Inhibitor ZE00-0388 to Phase 1 Clinical Trials

Page 1 of 3